Nastech changes name, focuses on gene-silencing : NEW YORK (AP) - After several months of mulling over a plan to spin off its RNAi gene-silencing therapy business, Nastech Pharmaceutical Inc. said Tuesday it will instead shift the entire company's focus to this growing...
Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.
Get the Latest Nastech Pharmaceutical stock Price, quotes, trades and FREE Nastech Pharmaceutical stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Nastech Pharmaceutical (NSTK) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.